Activity of decitabine combined with all-trans retinoic acid in oligoblastic acute myeloid leukemia: results from a randomized 2x2 phase II trial (DECIDER)

Detalles Bibliográficos
Autores principales: Rummelt, Christoph, Grishina, Olga, Schmoor, Claudia, Crysandt, Martina, Heuser, Michael, Götze, Katharina S., Schlenk, Richard F., Döhner, Konstanze, Salih, Helmut R., Heil, Gerhard, Müller-Tidow, Carsten, Brugger, Wolfram, Kündgen, Andrea, de Wit, Maike, Giagounidis, Aristoteles, Scholl, Sebastian, Neubauer, Andreas, Krauter, Jürgen, Bug, Gesine, Al-Ali, Haifa Kathrin, Wäsch, Ralph, Becker, Heiko, May, Annette M., Duyster, Justus, Hackanson, Björn, Ganser, Arnold, Döhner, Hartmut, Lübbert, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388266/
https://www.ncbi.nlm.nih.gov/pubmed/36601981
http://dx.doi.org/10.3324/haematol.2022.282258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388266/
https://www.ncbi.nlm.nih.gov/pubmed/36601981
http://dx.doi.org/10.3324/haematol.2022.282258

Ejemplares similares